Table I.
Clinicopathological data for 48 AML patients taken in a study
| Number of patients | 48 |
| Gender(M/F) | 23/25 |
| Age of study, range (median) | 25–73 (52year) |
| Peripheral blood values | |
| WBC (K/μl) range (median) | 0.3–70.6 (4.8) |
| Bone marrow blasts, range (median) | 5–94% (29%) |
| WHO | |
| AML –t (9:11)(p22;q23) | 2 |
| AML-inv(16)(p13.1;q22) | 1 |
| AML, NOS | 31 |
| AML-t | 3 |
| AML-MDS | 9 |
| Other | 2 |
| FAB | |
| M0 | 2 |
| M1 | 7 |
| M2 | 13 |
| M4 | 4 |
| M5 | 5 |
| M6 | 3 |
| RAEB-T | 7 |
| Other/NA | 6 |
| Mix | 1 |
| Cytogenetic findings | |
| Recurrent genetic abnormalities | 3 |
| Diploid | 18 |
| 1–2 Abnormalities | 11 |
| Complex (>3 abnormalities) | 16 |
| Mutation Status (Positive/Tested) | |
| NRAS | 4/40 (10%) |
| KRAS | 2/40 (5%) |
| KIT | 1/24 (4 %) |
| FLT3-D835 | 3/46 (7%) |
| FLT3-ITD | 5/46 (11%) |
| NPM1 | 1/4 (25%) |